Nectar Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21

Sales

787.40

792.09

791.67

919.23

749.02

Operating profit

83.14

62.41

34.44

95.74

63.10

Interest

39.78

38.14

42.35

35.06

43.75

Gross profit

44.59

35.34

3.16

61.73

29.59

EPS (Rs)

0.38

0.13

-0.83

0.95

0.18

Other income

1.24

11.08

11.07

1.05

10.24

Stock adjustment

-17.49

27.14

-22.51

16.07

-1.10

Raw material

550.87

539.81

620.77

658.10

548.78

Power and fuel

-

-

-

-

-

Employee expenses

48.17

39.11

37.75

38.94

35.61

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

122.71

123.62

121.21

110.38

102.64

Provisions made

-

-

-

-

-

Depreciation

31.01

30.64

29.49

28.54

28.43

Taxation

5.02

1.86

-7.79

11.81

-2.78

Net profit / loss

8.57

2.84

-18.53

21.39

3.93

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

22.43

22.43

22.43

22.43

22.43

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

10.56

7.88

4.35

10.42

8.42

GPM (%)

5.65

4.40

.39

6.71

3.90

NPM (%)

1.09

0.35

-2.31

2.32

0.52